高级检索
当前位置: 首页 > 详情页

USP3: Key deubiquitylation enzyme in human diseases

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China [2]Medical School, Kunming University of Science and Technology, Kunming, China [3]The Third Affiliated Hospital, Kunming Medical University, Kunming, China [4]The First Affiliated Hospital, Kunming Medical University, Kunming, China [5]Academy of Biomedical Engineering, Kunming Medical University, Kunming, China
出处:
ISSN:

关键词: cancer deubiquitylation DNA damage posttranslation modification USP3

摘要:
Ubiquitination and deubiquitylation are pivotal posttranslational modifications essential for regulating cellular protein homeostasis and are implicated in the development of human diseases. Ubiquitin-specific protease 3 (USP3), a member of the ubiquitin-specific protease family, serves as a key deubiquitylation enzyme, playing a critical role in diverse cellular processes including the DNA damage response, cell cycle regulation, carcinogenesis, tumor cell proliferation, migration, and invasion. Despite notable research efforts, our current understanding of the intricate and context-dependent regulatory networks governing USP3 remains incomplete. This review aims to comprehensively synthesize existing published works on USP3, elucidating its multifaceted roles, functions, and regulatory mechanisms, while offering insights for future investigations. By delving into the complexities of USP3, this review strives to provide a foundation for a more nuanced understanding of its specific roles in various cellular processes. Furthermore, the exploration of USP3's regulatory networks may uncover novel therapeutic strategies targeting this enzyme in diverse human diseases, thereby holding promising clinical implications. Overall, an in-depth comprehension of USP3's functions and regulatory pathways is crucial for advancing our knowledge and developing targeted therapeutic approaches for human diseases.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, China [2]Medical School, Kunming University of Science and Technology, Kunming, China
通讯作者:
通讯机构: [3]The Third Affiliated Hospital, Kunming Medical University, Kunming, China [5]Academy of Biomedical Engineering, Kunming Medical University, Kunming, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:58812 今日访问量:0 总访问量:1866 更新日期:2025-03-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)